Clinical trial
Clinical Efficacy and Human Factors Validation Testing for Prescription Home Use of the Erchonia Corporation EVRL™ for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
NCT05291975 is registered in ClinicalTrials.gov with Erchonia Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Human Factors Validation Testing for Prescription Home Use of the Erchonia Corporation EVRL™ for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
- Lead sponsor
- Erchonia Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 17, 2022
- Completion date
- December 12, 2024
- Enrollment
- 64 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathy, diabetic, neuropathy, painful, neuropathy;peripheral